| Term 
 
        | Name 4 rheumatic diseases with autoimmune etiology? |  | Definition 
 
        | 1)Rheumatoid arthritis 2)Systemic lupus erythematosus
 3)Sjogren sydrome
 4)Scleroderma
 |  | 
        |  | 
        
        | Term 
 
        | Autoimmune rheumatic diseases are characterized by the presence of 1 or more autoantibodies directed against what? |  | Definition 
 
        | 1 or more cellular components: -Cell surface
 -cytoplasm
 -nuclear envelope
 -nucleus of the cell
 |  | 
        |  | 
        
        | Term 
 
        | Autoantibodies to nuclear antigens is the hallmark of what diseases? |  | Definition 
 
        | systemic rheumatic diseases |  | 
        |  | 
        
        | Term 
 
        | What is a general definition for rheumatoid arthritis? |  | Definition 
 
        | Autoimmune polyarticular disease affecting joints in symmetrical pattern. |  | 
        |  | 
        
        | Term 
 
        | Give the general order in which RA starts in the joints |  | Definition 
 
        | -MCP-PIP-MTP-Wrists-Knees-Elbows-Ankles-Hips-Shoulders **Advanced cases: cervical spine- temporamandibular and sternociavicular joints
 |  | 
        |  | 
        
        | Term 
 
        | What are the main differences between rheumatoid arthritis and osteoarthritis? |  | Definition 
 
        | -Osteoarthritis involves the spine -RA has a larger involvement in the hands and feet
 |  | 
        |  | 
        
        | Term 
 
        | Why is it important to adequately treat RA early in the disease process? |  | Definition 
 
        | RA will typically lead to severe, disabling joint deformities w/in a few months. Also extra-articular manifestations |  | 
        |  | 
        
        | Term 
 
        | List some of the extraarticular manifestations of rheumatoid arthritis (7) *Include examples |  | Definition 
 
        | 1)Skin: rheumatoid nodules on extensor surfaces and pressue points 2)Bone: risk factor for osteoporosis
 3)Blood: anemia of chronic disease
 4)Eyes (scleritis, episcleritis, rarely uveitis): scleritis may lead to scleromalacia perforans
 5)Lungs: interstitial fibrosis, rheumatoid nodules in the lung, pleural disease
 6)Heart: coronary artery disease; risk factor for MI, pericarditis, myocarditis
 7) Neurologic: peripheral neuropathy, numbness in hands and feet
 |  | 
        |  | 
        
        | Term 
 
        | What is the age of onset for RA? |  | Definition 
 
        | Patient may present at any age. -Highest incidence found among persons aged 40-70.
 -Women in late childbearing age are most commonly affected
 -Men in the sixth to eighth decade are most commonly affected
 |  | 
        |  | 
        
        | Term 
 
        | What is the lifetime risk of developing RA for women? men? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the gender preference for RA? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the genetic contribution to RA? Do most patients have a positive family history?
 What 2 genes appear to predispose patients to RA?
 |  | Definition 
 
        | 1)~65% 2)No
 3)HLA-DR4 and HLA-DR1
 |  | 
        |  | 
        
        | Term 
 
        | Describe the pathophysiology of rheumatoid arthritis? |  | Definition 
 
        | -Autoimmune in nature w/ antibodies attacking the joint synovia -Involves both the innate and adaptive immune system with various cell types and cytokines.
 |  | 
        |  | 
        
        | Term 
 
        | What are the two key players in joint destruction? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the common clinical features of RA? (8) |  | Definition 
 
        | 1)Inflammation of joints, tendons, and/or bursae 2)Early morning joint stiffness lasting >1 hr & easing w/ physical activity
 3)Inflammation leads to: joint swelling (synovitis), joint tenderness, decreased range of motion, & morning stiffness.
 4)Fatigue
 5)Weakness
 6)Weight loss
 7)Low-grade fevers (less specific)
 8)Activities of daily living are affected
 |  | 
        |  | 
        
        | Term 
 
        | What is a very characteristic factor of RA, having to do w/ initial pattern of joint involvement? |  | Definition 
 
        | -Generally symmetrical. Most commonly polyarticular. Some may present w/ oligoarticular involvement but then it is at least 3 joints. |  | 
        |  | 
        
        | Term 
 
        | Clinical features of RA: What joints are involved first?
 Name 3 classical joints involved?
 |  | Definition 
 
        | 1)Small joints involved first. Large joints come later in the course of the disease. 2)PIP, MCP, and MTP
 |  | 
        |  | 
        
        | Term 
 
        | List the most important positive findings for the diagnosis of RA? (5) |  | Definition 
 
        | 1)Joint swelling and pain 2)Positive antibodies (rheumatoid factor (RF) and cyclic citrullinated peptide (CCP))
 3)Erosive changes on radiography
 4)Joint symptoms lasting >6 wks, worse in the morning w/ improvement w/ movement
 5)Elevated acute-phase reactants (ERS, CRP)
 |  | 
        |  | 
        
        | Term 
 
        | According to ACR diagnosis (score based on joints involved), a patient w/ a score of ____ is likely to have RA. ex: 0= 1 large joint,1= 2-10 large joints,2= 1-3 small joints, 3= 4-10 small joints, 5= >10 joints
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the 3 pharmacologic classes used in the treatment of RA? |  | Definition 
 
        | 1)Adjunctive medication (analgesics) 2)Nonbiologic DMARDs
 3)Biologic DMARDs
 *want to target the immune system
 |  | 
        |  | 
        
        | Term 
 
        | What is systemic lupus erythematosus (SLE)? |  | Definition 
 
        | A chronic autoimmune multisystem disease w/ a fluctuating course. -commonly affects skin & joints
 -can involve any body system
 |  | 
        |  | 
        
        | Term 
 
        | Who is most commonly affected by systemic lupus erythematosus? |  | Definition 
 
        | -childbearing year for women aged 20-45 (80% cases), but does occur in all age groups of both sexes before 8 yrs old -<15 yrs of age, incidence 0.5/100,000 in US
 |  | 
        |  | 
        
        | Term 
 
        | The diagnosis of SLE is made on what? |  | Definition 
 
        | Clinical grounds and the presence of antibodies to nuclear antigens (ANA) and to ds-DNA |  | 
        |  | 
        
        | Term 
 
        | What are the most common presentation/signs and symptoms of SLE? |  | Definition 
 
        | -butterfly rash on face or malar flush -low-grade fever
 -nondeforming arthritis
 **range of presentation that depends on which body systems are involved
 |  | 
        |  | 
        
        | Term 
 
        | How do you control symptoms of SLE, mild? severe? |  | Definition 
 
        | 1)Rest, NSAIDs for arthraigia and hydroxychloroquine for rashes, avoidance of sunlight 2)Systemic corticosteroids and immunosuppressive agents, including DMARDs
 |  | 
        |  | 
        
        | Term 
 
        | What is the incidence of getting systemic lupus erythematosus? What is the prevalence?
 |  | Definition 
 
        | 1)varies from 1.8-7.6/100,000 per year in the US 2)20/100,000 in the US
 |  | 
        |  | 
        
        | Term 
 
        | What is gender and ethinicity are more commonly affected by SLE? |  | Definition 
 
        | -Female: male ratio vary from 3:1 to 9:1 in adults, and 2:1 in prepubertal children -More common in African Americans
 |  | 
        |  | 
        
        | Term 
 
        | What is the initiating event in systemic lupus erythematosus? |  | Definition 
 
        | Event: abnormal form of apoptotic cell death, where cells undergo apoptosis and a antigenic bleb for self-DNA forms on the surface of the dead cell -impairment of normal phagocytic clearance processes for apoptotic cells
 -antigenic apoptotic cells are transferred to lymphoid tissue & taken up by APCs for presentation to T-cells
 -activated T-cells stimulate B-cells to produce antibodes which attack antigenic material, forming immune complexes that deposit in tissue
 |  | 
        |  | 
        
        | Term 
 
        | What are some of the adverse environmental exposure settings in which the abnormal form of apoptotic cell death occurs in SLE? |  | Definition 
 
        | -sunlight exposure (associated w/ disease onset and flares) -viral infection (Epstein-Barr virus exposure associated w/SLE in children)
 -Certain drugs
 |  | 
        |  | 
        
        | Term 
 
        | How is drug-induced Lupus different from SLE? |  | Definition 
 
        | Epidemiologically: -Male to female distribution equal.
 -Average age of onset 50yrs
 Clinically:
 -arthralgias or arthritis
 -1/2 patients have serositis
 Serologically:Drug induced SLE
 -95% patients are antihistone +
 -Sm and dsDNA are rarely +
 Serology: SLE
 -most patients dsDNA +
 -80% patients antihistone +
 |  | 
        |  | 
        
        | Term 
 
        | List the most common drugs involved in drug-induced Lupus? (3 most common) (7 others) |  | Definition 
 
        | Most common: 1)Isoniazid
 2)Hydralazine
 3)Procainamide
 Others:
 1)Minocycline
 2)Aldomet
 3)Diltiazem
 4)Infliximab
 5)Sulfas
 6)Amiodarone
 7)Beta blockers
 |  | 
        |  | 
        
        | Term 
 
        | What is a malar rash? What is a discoid rash?
 |  | Definition 
 
        | 1)fixed erythema sparing the nasolabial fold 2)erythematous patches w/ keratotic scaling. scarring
 |  | 
        |  | 
        
        | Term 
 
        | List some other clinical presentations of SLE? (12) |  | Definition 
 
        | 1)Fever: low-grade (active disease) or high fever (possible infection) 2)Malaise and chronic fatigue
 3)Skin rashes: malar rash and discoid rash
 4)Scalp lesions and alopecia
 5)Photosensitivity
 6)Mucocutaneous: ulcers in nose & mouth
 7)Pain & swelling joints: polyarthritis is symmetrical, nonerosive, & nondeforming
 8)Arthralgia: severe pain in joints w/ only tenderness found clinically
 9)Chest complaints: hemoptysis, dyspnea, orthopnea, chest pain
 10)Vasculitic rashes & splinter hemorrhages in nail bed
 11)Peripheral extremity changes induced by cold: Raynaud's phenomenon
 12)Abdominal pain & tenderness: enlarged liver & spleen, constipation, vascular insult, peritoneal serositis, chronic pancreatitis
 |  | 
        |  | 
        
        | Term 
 
        | What are some cerebral symptoms of SLE? (6) |  | Definition 
 
        | 1)Mood disturbance (rare psychosis) 2)Cognitive dysfunction
 3)Agoraphobia
 4)HA (occasional migrainous
 5)Movement disorders (St Vitus dance)
 6)Memory loss
 |  | 
        |  | 
        
        | Term 
 
        | The most common form of neurologic involvement is ____ ___, occuring in __% of SLE patients 10 years after diagnosis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the ocular presentations of SLE? (5) |  | Definition 
 
        | 1)scleritis 2)episceritis
 3)KCS, uveitis
 4)rare optic neuritis
 5)cotton wool spots
 |  | 
        |  | 
        
        | Term 
 
        | Describe the sensory or sensorimoter clinical presentations for SLE? |  | Definition 
 
        | -symptoms of a stroke may be apparent -spinal cord disease may mimic MS
 |  | 
        |  | 
        
        | Term 
 
        | What 2 diseases/conditions must be ruled-out when diagnosing SLE? |  | Definition 
 
        | 1)Chronic cutaneous lupus (rarely progresses to systemic disease-5%) 2)Drug-induced lupus erythematosus
 |  | 
        |  | 
        
        | Term 
 
        | For a patient to be diagnosed with SLE they must. . . |  | Definition 
 
        | -Have biopsy-proven lupus nephritis w/ ANA or anti-dsDNA -OR: satisfy 4 of ACR criteria, including at least 1 clinical and 1 immunologic ctriterion
 ex: ACR criteria
 Derm: malar rash, discoid rash, photosensitivity
 Oral ulcers; serositis; arthritis; nephritis
 Neurologic: psychosis, seizures, stroke
 |  | 
        |  | 
        
        | Term 
 
        | For a patient to be diagnosed with drug-induced SLE they must. . . |  | Definition 
 
        | -Have acute lupus-like clinical signs and symptoms not involving a major organ -Antihistone antibodies w/out dsDNA
 -Concurrent use of drug considered to induce SLE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Autoimmune disease should be dealt w/ using DMARDs (biologic & nonbiologic) -NSAIDs (antiinflammatory doses)
 -Intermittent corticosteroids
 |  | 
        |  | 
        
        | Term 
 
        | How do you treat drug-induced SLE? |  | Definition 
 
        | -Stop implicated medication first (disease tends to resolve w/in 6 months of drug discontinuation) -NSAIDs
 -Antimalarials
 -Ocassionally steroids and cytotoxic agents for drug-induced vasculitis or serositis
 |  | 
        |  | 
        
        | Term 
 
        | What is Sjogren Syndrome (SS)? |  | Definition 
 
        | A systemic autoimmune disease that mainly affects the exocrine glands and usually presents as persistent dryness of the mouth & eyes due to functional impairment of the salivary and lacrimal glands |  | 
        |  | 
        
        | Term 
 
        | What is the histologic characteristic of Sjogren on a biopsy? |  | Definition 
 
        | Focal lymphocytic infiltration of exocrine glands |  | 
        |  | 
        
        | Term 
 
        | True/False.  Sjorgrens is classified secondary when symptoms are found in association w/ other systemic autoimmune diseases (RA, SLE). |  | Definition 
 
        | True. Only primary disease in otherwise healthy patients |  | 
        |  | 
        
        | Term 
 
        | What are some non-sicca signs and symptoms of Sjogrens syndrome? |  | Definition 
 
        | 1)Fever 2)Generalized pain
 3)Fatigue
 4)Weakness
 5)Sleep disturbances
 6)Anxiety and depression
 **much greater impact on quality of life of patients than sicca features
 |  | 
        |  | 
        
        | Term 
 
        | What is the prevalence of Sjogrens? What is the incidence?
 |  | Definition 
 
        | 1)~2-4 million persons 2)4/100,000 primary
 Secondary SS: 11-19% in SLE patients; 7% in RA patients
 |  | 
        |  | 
        
        | Term 
 
        | Who is most commomly affected by Sjogrens? Ethnicity, gender, age |  | Definition 
 
        | -Primarily affects Caucasian premenopausal women -Female:male ratio: 14:1 to 24:1
 -All age groups are affected, onset typically between 40-60 yrs old
 |  | 
        |  | 
        
        | Term 
 
        | What areas of the body are affected by Sjogrens that have clinical presentation? (14) |  | Definition 
 
        | 1)Mouth- oral dryness 2)Eyes- corneal ulcers, conjunctivitis
 3)Skin- cutaneous dryness, lesions
 4)Nose and Throat- dysphagia
 5)Joints- arthraigia, non-erosive symmetric arthritis
 6)Lungs-obstructive chronic pneumopathy, lung disease
 7)Cardiovascular-Raynaud phenomenon, pericarditis, autonomic disturbances
 8)Liver-associated w/ Hep C virus infection, primary biliary cirrhosis, & autoimmune hep
 9)Kidneys-renal tubular acidosis, glomerulonephritis
 10)CNS- peripheral neuropathy (common), cranial nerve involvement (V, VII, & VIII)
 11)GIT- altered esophageal motility, chronic gastritis, less frequent malabsorption syndromes
 12)Ears- sensorineural hearing loss
 13)Thyroid- 1/3 have thyroid disease
 14)Salivary glands- chronic or episodic swelling of major salivary glands (10-20% patients)
 |  | 
        |  | 
        
        | Term 
 
        | Describe the clinical presentation seen in mouth of a patient w/ Sjogrens? % affected, signs, symptoms |  | Definition 
 
        | -Xerostomia occurs in >95% of patients -oral dryness (xerostomia), soreness, caries, periodontal disease, oral candidiasis, parotid swelling
 -Surface of tongue becomes red & lobulated w/ partial or complete depapillation
 |  | 
        |  | 
        
        | Term 
 
        | Describe the clinical presentation seen w/ skin of a patient w/ Sjogrens? |  | Definition 
 
        | -Exocrine glands of skin leads to cutaneous dryness -Females: dryness of vagina & vulva may result in dyspareunia & pruritus
 -Wide spectrum of cutaneous lesions,  small-vessel vasculitis most frequent
 -Photosensitive to UV exposure
 |  | 
        |  | 
        
        | Term 
 
        | Describe the clinical presentation seen in nose and throat of a patient w/ Sjogrens? |  | Definition 
 
        | -Reduction or absence of respiratory tract glandular secretions lead to dryness of nose, throat, & trachea -Lead to hoarseness & chronic, nonproductive cough
 -Dysphagia: difficulty swelling present
 |  | 
        |  | 
        
        | Term 
 
        | Describe the clinical presentation seen in joints of a patient w/ Sjogrens? |  | Definition 
 
        | -Arthraigia, non-erosive symmetric arthritis -Joint involvement, generalized arthraigias, seen in 25-75% of patients
 -Joint deformity & mild erosions rare, except for cases associated w/ RA
 |  | 
        |  | 
        
        | Term 
 
        | About how many (%) of patients w/ primary Sjogrens have thyroid disease? What is most common? |  | Definition 
 
        | 1/3 Subclinical hypothyroidism most frequent, especially in patients w/ antithyroid autoantibodies
 |  | 
        |  | 
        
        | Term 
 
        | Describe the clinical presentation seen in salivary glands of a patient w/ Sjogrens? |  | Definition 
 
        | -Chronic or episodic swelling of major salivary glands (parotid & submandibular glands) reported in 10-20% of patients -Start unilaterally but become bilateral
 |  | 
        |  | 
        
        | Term 
 
        | What are the 4 lab diagnoses for Sjogrens? |  | Definition 
 
        | 1)Elevated ERS 2)Leukopenia & thrombocytopenia
 3)Positive ANA and/or RF: secondary SS associated w/ other rheumatic disease (inflam markers present & elevated)
 4)Salivary gland biopsy: focal lymphocytic sialadenitis in sampled glands
 |  | 
        |  | 
        
        | Term 
 
        | What are focal lymphocytic sialadenitis? |  | Definition 
 
        | Multiple, dense aggregates of 50 or more lymphocytes in perivascular or periductal areas |  | 
        |  | 
        
        | Term 
 
        | How do you treat a patient for Sjogrens? |  | Definition 
 
        | 1)Address the symptoms- ex: dry eye w/ artifical tears 2)Treat andy underlying autoimmune rheumatic disease
 3)Severe cases: treat w/ DMARD therapy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Relatively rare chronic disorder characterized by diffuse fibrosis of skin and internal organs (hardening). Present in virtually all patients w/ Raynaud phenomenon and antinuclear antibodies
 |  | 
        |  | 
        
        | Term 
 
        | Scleroderma is a systemic disease that most commonly targets what? (7) |  | Definition 
 
        | 1)Peripheral circulation 2)Muscles
 3)Joints
 4)Gastrointestinal tract
 5)Lung
 6)Heart
 7)Kidney
 |  | 
        |  | 
        
        | Term 
 
        | What is the prevalence of scleroderma? |  | Definition 
 
        | ~250 patients/million in US |  | 
        |  | 
        
        | Term 
 
        | What is the gender affect of scleroderma and age of onset? |  | Definition 
 
        | Female to Male ratio= 4-5:1 Average age of diagnosis: ~50 yrs
 |  | 
        |  | 
        
        | Term 
 
        | List the systemic features, in order of frequency, for scleroderma? (9) |  | Definition 
 
        | 1)Raynaud phenomenon (vascular constriction in digits) 2)Gastroesophageal reflux (w/ or w/out dysmotility)
 3)Skin changes
 4)Swollen fingers
 5)Arthraigias
 6)Pulmonary fibrosis
 7)Pulmonary/ Systemic hypertension
 8)Renal involvement: scleroderma renal crisis (SRC) develops in ~10% of patients. Onset malignant hypertension.
 9)Fatigue
 |  | 
        |  | 
        
        | Term 
 
        | What is the most dramatic clinical feature of scleroderma? |  | Definition 
 
        | -Skin fibrosis (thickening -Prominent skin changes: marked telangiectasia that occurs on skin of face, palmer surface of hands, & mucus membranes
 |  | 
        |  | 
        
        | Term 
 
        | What symptoms are encountered in the early presentation of scleroderma? |  | Definition 
 
        | 1)Musculoskeletal discomfort 2)Fatigue
 3)Weight loss
 4)Heartburn associated w/ Gastroesophageal reflux disease
 |  | 
        |  | 
        
        | Term 
 
        | What are the 2 types of scleroderma? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Describe limited scleroderma? |  | Definition 
 
        | -long history of Raynaud phenomenon -gastroesophageal reflux & dysphagia
 -swelling or skin thickening of fingers
 -infrequent systemic symptoms such as arthralgias, weight loss, & dyspnea
 |  | 
        |  | 
        
        | Term 
 
        | Describe diffuse scleroderma? |  | Definition 
 
        | -new onset of Raynaud phenomenon -rapid change in skin texture w/ new onset of edema, pruritus, and pain
 -signif. systemic symptoms w/ severe arthraigias, weight loss, & tendon friction rubs
 -early evidence of internal organ involvement such as dyspnea or hypertension
 |  | 
        |  | 
        
        | Term 
 
        | The American College of Rheumatology diagnosis criteria for scleroderma includes what? |  | Definition 
 
        | -either thickened skin changes proximal to metacarpophalangeal joints or at least 2 of the following: -Sclerodactyly
 -Digital pitting
 -Bibasilar pulmonary fibrosis
 |  | 
        |  | 
        
        | Term 
 
        | How would you treat scleroderma? |  | Definition 
 
        | -No single disease modifying drug exists -treat each individual organ dysfunction ex: treat renal hypertension w/ ACE inhibitor
 |  | 
        |  |